Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00493675
Other study ID # R06089
Secondary ID
Status Withdrawn
Phase Phase 1
First received June 27, 2007
Last updated June 24, 2010
Start date June 2006
Est. completion date June 2010

Study information

Verified date February 2009
Source University of Tampere
Contact n/a
Is FDA regulated No
Health authority Finland: Terveydenhuollon oikeusturvakeskus (National Authority for Medicolegal Affairs)
Study type Interventional

Clinical Trial Summary

Endoscopic sphincterotomy and temporary stenting is a routine treatment for post cholecystectomy cystic duct leakage. The draw back is that the plastic stent need to be removed later in a second intervention. Our studies with animal models have demonstrated that biodegradable biliary stent is at least as good as conventional plastic stent to heal that kind of leakage. In this pilot study the biodegradable biliary stent is inserted endoscopically to patients with confirmed cystic duct leakage to demonstrate the efficacy in human setting.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 2010
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with confirmed post cholecystectomy cystic duct leakage requiring endoscopic treatment

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
endoscopic bile duct stenting


Locations

Country Name City State
Finland Tampere University Hospital Tampere

Sponsors (1)

Lead Sponsor Collaborator
University of Tampere

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical healing of bile leakage 1 month
Secondary Laboratory tests for liver function, ultra sound for bile collections and bile duct diameter and abdominal plain X-ray for stent degradation 6 months